ULGX - Urologix, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue14,23516,59017,027
Cost of Revenue8,1428,4078,645
Gross Profit6,0938,1838,382
Operating Expenses
Research Development1,6252,2692,189
Selling General and Administrative8,2679,89310,248
Non Recurring3,036160160
Total Operating Expenses13,02312,426-
Operating Income or Loss-6,930-3,922-4,145
Income from Continuing Operations
Total Other Income/Expenses Net-1520-13
Earnings Before Interest and Taxes-7,624-4,278-4,640
Interest Expense---
Income Before Tax-7,624-4,278-4,640
Income Tax Expense-161455
Minority Interest---
Net Income From Continuing Ops-7,608-4,086-4,695
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,608-4,292-4,695
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,608-4,292-4,695